Excellon Announces Closing of Brokered Private Placement of Units for Gross Proceeds of C$8.0 Million, Including Full Exercise of the Agents' Option and Lead Investment by Eric Sprott

Stock Information for Acasti Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Acasti Pharma Inc.

Excellon Announces Availability of Meeting Materials, Alternative Voting Procedures and Adoption of Amended Share Incentive Plan
Excellon Continues to Advance Mallay Towards Restart
Excellon Announces Closing of Debt Settlement
Excellon Announces Closing of Brokered Private Placement of Common Shares for Gross Proceeds of C$12 Million, Including Full Exercise of the Agents' Option
Excellon Announces Upsize of Brokered Private Placement of Common Shares for Gross Proceeds of up to C$11 Million
Excellon Announces Brokered Private Placement of Common Shares for Gross Proceeds of up to C$8 Million
Excellon Closes Glencore Offtake and Financing
Excellon Resources Advances Mallay Silver Mine Towards a Near-Term Restart

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.